首页 / 院系成果 / 成果详情页

Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment 期刊论文

编号：

247c98c7-3311-4e0d-8725-3224254289fa
作者：

Cai, Fengfeng#*^[1]Luis, Manuel Antonio Falar#^[1]Lin, Xiaoyan#^[1]Wang, Minghong*^[2,3]Cai, Lu^[1];Cen, Chunmei^[1];Biskup, Ewelina^[4]
语种：

英文
期刊：

MOLECULAR AND CLINICAL ONCOLOGY ISSN：2049-9450 2019 年 11 卷 1 期 (15 - 23) ; JUL
收录：
关键词：

anthracyclines breast cancer doxorubicin cardiotoxicity risk factors prevention treatment
摘要：

Anthracyclines are highly effective chemotherapeutic agents, used for a wide variety of malignancies. Cardiotoxicity is a well-recognized side effect of anthracycline therapy that limits the total amount of drug administered and can cause heart failure in some patients. Most experimental data support oxidative stress as the etiology of anthracycline-induced cardiotoxicity. The objective of this paper was to provide a review of the clinical classification, risk factors, monitoring and prevention of anthracycline-induced cardiotoxicity in patients with breast cancer.
推荐引用方式
GB/T 7714：

Cai Fengfeng,Luis Manuel Antonio Falar,Lin Xiaoyan, et al. Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment [J].MOLECULAR AND CLINICAL ONCOLOGY,2019,11(1):15-23.
APA：

Cai Fengfeng,Luis Manuel Antonio Falar,Lin Xiaoyan,Wang Minghong,&Biskup Ewelina.(2019).Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment .MOLECULAR AND CLINICAL ONCOLOGY,11(1):15-23.
MLA：

Cai Fengfeng, et al. "Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment" .MOLECULAR AND CLINICAL ONCOLOGY 11,1(2019):15-23.
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：53  下载次数：0

分享到：

浏览次数：53

下载次数：0

打印次数：0